Nomura Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,568,692
Closed -$4.95M 1733
2020
Q3
$4.95M Buy
1,568,692
+156,246
+11% +$499K 0.01% 464
2020
Q2
$4.14M Buy
1,412,446
+361,008
+34% +$1.14M 0.01% 421
2020
Q1
$2.96M Sell
1,051,438
-21,339
-2% -$68.8K 0.01% 393
2019
Q4
$3.48M Buy
1,072,777
+249,472
+30% +$724K 0.01% 515
2019
Q3
$1.76M Sell
823,305
-152,706
-16% -$408K 0.01% 677
2019
Q2
$2.99M Buy
976,011
+26,525
+3% +$86K 0.01% 601
2019
Q1
$3.53M Buy
949,486
+32,539
+4% +$110K 0.01% 530
2018
Q4
$2.65M Buy
916,947
+44,944
+5% +$123K 0.01% 639
2018
Q3
$2.22M Buy
872,003
+22,752
+3% +$55.8K 0.01% 704
2018
Q2
$1.99M Hold
849,251
0.01% 723
2018
Q1
$2.5K Buy
849,251
+22,925
+3% +$62.6K ﹤0.01% 775
2017
Q4
$2.27M Buy
826,326
+28,192
+4% +$86.6K ﹤0.01% 848
2017
Q3
$2.7M Buy
798,134
+20,721
+3% +$57.6K 0.01% 758
2017
Q2
$1.93M Buy
777,413
+17,073
+2% +$39.3K ﹤0.01% 845
2017
Q1
$1.72M Buy
+760,340
New +$1.68M ﹤0.01% 703
2016
Q2
Sell
-39,109
Closed -$129K 1888
2016
Q1
$129K Sell
39,109
-48,051
-55% -$150K ﹤0.01% 1356
2015
Q4
$310K Buy
87,160
+24,196
+38% +$101K ﹤0.01% 1296
2015
Q3
$340K Sell
62,964
-20,556
-25% -$118K ﹤0.01% 1127
2015
Q2
$557K Buy
83,520
+69,819
+510% +$468K ﹤0.01% 1228
2015
Q1
$99K Sell
13,701
-171,482
-93% -$1.24M ﹤0.01% 1604
2014
Q4
$1.45M Sell
185,183
-64,867
-26% -$513K ﹤0.01% 1167
2014
Q3
$1.91M Buy
250,050
+141,766
+131% +$1.32M 0.01% 1137
2014
Q2
$1.04M Sell
108,284
-99,934
-48% -$891K ﹤0.01% 1420
2014
Q1
$1.73M Sell
208,218
-52,189
-20% -$447K ﹤0.01% 1244
2013
Q4
$2.21M Buy
260,407
+52,635
+25% +$444K 0.01% 667
2013
Q3
$1.65M Buy
207,772
+4,012
+2% +$32.3K 0.01% 896
2013
Q2
$1.57M Buy
+203,760
New +$1.59M 0.01% 788

Other funds holding PDLI